BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15073121)

  • 21. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
    Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
    Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas.
    Chen Z; Sager R
    Mol Med; 1995 Jan; 1(2):153-60. PubMed ID: 8529094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
    Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
    Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation.
    Richards JS; Hernandez-Gonzalez I; Gonzalez-Robayna I; Teuling E; Lo Y; Boerboom D; Falender AE; Doyle KH; LeBaron RG; Thompson V; Sandy JD
    Biol Reprod; 2005 May; 72(5):1241-55. PubMed ID: 15659705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
    Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
    Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia.
    Bertin N; Clezardin P; Kubiak R; Frappart L
    Cancer Res; 1997 Feb; 57(3):396-9. PubMed ID: 9012463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer.
    Aritake N; Tamaki Y; Masuda N; Nakano Y; Monden T; Noguchi S; Monden M
    Oncol Rep; 2004 Aug; 12(2):381-7. PubMed ID: 15254706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
    Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
    BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
    Andres SA; Wittliff JL
    Endocrine; 2011 Oct; 40(2):212-21. PubMed ID: 21858728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential gene expression profile in breast cancer-derived stromal fibroblasts.
    Singer CF; Gschwantler-Kaulich D; Fink-Retter A; Haas C; Hudelist G; Czerwenka K; Kubista E
    Breast Cancer Res Treat; 2008 Jul; 110(2):273-81. PubMed ID: 17899370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical correlations and prognostic relevance of Fn14 expression in breast carcinoma.
    Wang J; Liu Y; Wei MJ; Mi XY; Wang EH
    Histol Histopathol; 2013 Jul; 28(7):859-64. PubMed ID: 23300011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.